Your browser doesn't support javascript.
loading
A VEGFB-Based Peptidomimetic Inhibits VEGFR2-Mediated PI3K/Akt/mTOR and PLCγ/ERK Signaling and Elicits Apoptotic, Antiangiogenic, and Antitumor Activities.
Namjoo, Mohadeseh; Ghafouri, Hossein; Assareh, Elham; Aref, Amir Reza; Mostafavi, Ebrahim; Hamrahi Mohsen, Ali; Balalaie, Saeed; Broussy, Sylvain; Asghari, S Mohsen.
Afiliação
  • Namjoo M; Department of Biology, University Campus II, University of Guilan, Rasht P.O. Box 14155-6619, Iran.
  • Ghafouri H; Department of Biology, Faculty of Sciences, University of Guilan, Rasht P.O. Box 14155-6619, Iran.
  • Assareh E; Department of Biology, Faculty of Sciences, University of Guilan, Rasht P.O. Box 14155-6619, Iran.
  • Aref AR; Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
  • Mostafavi E; Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
  • Hamrahi Mohsen A; Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran P.O. Box 1841, Iran.
  • Balalaie S; Peptide Chemistry Research Center, K. N. Toosi University of Technology, Tehran P.O. Box 1841, Iran.
  • Broussy S; CiTCoM, UMR CNRS 8038, U1268 INSERM, UFR de Pharmacie, Faculté de Santé, Université Paris Cité, 75006 Paris, France.
  • Asghari SM; Institute of Biochemistry and Biophysics (IBB), University of Tehran, Tehran P.O. Box 1841, Iran.
Pharmaceuticals (Basel) ; 16(6)2023 Jun 20.
Article em En | MEDLINE | ID: mdl-37375853

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Pharmaceuticals (Basel) Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Pharmaceuticals (Basel) Ano de publicação: 2023 Tipo de documento: Article